A new app developed by Cornell computer science researchers helps users record highly accurate time-lapse videos of body parts – a surprisingly difficult task and an unmet need in remote medicine and telehealth applications.
An emerging class of anticancer drugs called EZH2 inhibitors may greatly enhance the potency of some cancer immunotherapies, according to a preclinical study led by Weill Cornell Medicine lymphoma researchers.
Many individuals seeking asylum in the United States show increased stress and pain symptoms that are associated with indications of cardiovascular disease, according to Weill Cornell Medicine researchers.
Specially packaged DNA secreted by tumor cells can trigger an immune response that inhibits the metastatic spread of the tumor to the liver, according to a study led by researchers at Weill Cornell Medicine.
Severe COVID-19 arises in part from the SARS-CoV-2 virus’s impact on mitochondria, tiny oxygen-burning power plants in cells, which can help trigger a cascade of organ- and immune system-damaging events, suggests a study by investigators at Weill Cornell Medicine.
A new method developed at Cornell provides tools and methodologies to compress hundreds of terabytes of genomic data to gigabytes, once again enabling researchers to store datasets in local computers.
A preclinical trial has identified a way to thwart the highly addictive nature of opioids such as morphine and oxycodone while maintaining the drugs’ ability to relieve pain.
Inhibiting an immune signaling protein may help preserve the protective layer surrounding nerve fibers in the brain during both Alzheimer’s disease and ordinary aging, a new study suggests.
Faculty from the Department of Public & Ecosystem Health in the Cornell University College of Veterinary Medicine, in partnership with the University of Pretoria in South Africa, have received an NIH P20 grant to establish the Center for Transformative Infectious Disease Research on Climate, Health and Equity in a Changing Environment (C-CHANGE).
